<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yan Q</submitter><funding>Foundation for the National Institutes of Health</funding><funding>National Natural Science Foundation of China</funding><funding>China Postdoctoral Science Foundation</funding><funding>NCI NIH HHS</funding><funding>Natural Science Foundation of Jiangsu Province</funding><pagination>6327</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10564894</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>N-acetyltransferase 10 (NAT10) is an N&lt;sup>4&lt;/sup>-acetylcytidine (ac&lt;sup>4&lt;/sup>C) writer that catalyzes RNA acetylation at cytidine N&lt;sup>4&lt;/sup> position on tRNAs, rRNAs and mRNAs. Recently, NAT10 and the associated ac&lt;sup>4&lt;/sup>C have been reported to increase the stability of HIV-1 transcripts. Here, we show that NAT10 catalyzes ac&lt;sup>4&lt;/sup>C addition to the polyadenylated nuclear RNA (PAN), a long non-coding RNA encoded by the oncogenic DNA virus Kaposi's sarcoma-associated herpesvirus (KSHV), triggering viral lytic reactivation from latency. Mutagenesis of ac&lt;sup>4&lt;/sup>C sites in PAN RNA in the context of KSHV infection abolishes PAN ac&lt;sup>4&lt;/sup>C modifications, downregulates the expression of viral lytic genes and reduces virion production. NAT10 knockdown or mutagenesis eras</pubmed_abstract><journal>Nature communications</journal><pubmed_title>NAT10-dependent N&lt;sup>4&lt;/sup>-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation.</pubmed_title><pmcid>PMC10564894</pmcid><funding_grant_id>BK20180084</funding_grant_id><funding_grant_id>82372243</funding_grant_id><funding_grant_id>R01 CA213275</funding_grant_id><funding_grant_id>82241067</funding_grant_id><funding_grant_id>81730062</funding_grant_id><funding_grant_id>81761128003</funding_grant_id><funding_grant_id>BK20180681</funding_grant_id><funding_grant_id>81902639</funding_grant_id><funding_grant_id>82172262</funding_grant_id><funding_grant_id>2019TQ0158</funding_grant_id><funding_grant_id>31800148</funding_grant_id><funding_grant_id>32170151</funding_grant_id><funding_grant_id>R01CA213275</funding_grant_id><funding_grant_id>2019M661889</funding_grant_id><funding_grant_id>81871642</funding_grant_id><funding_grant_id>82072275</funding_grant_id><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Gao SJ</pubmed_authors><pubmed_authors>Yan Q</pubmed_authors><pubmed_authors>Ma X</pubmed_authors><pubmed_authors>Lu C</pubmed_authors><pubmed_authors>Jia X</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>NAT10-dependent N&lt;sup>4&lt;/sup>-acetylcytidine modification mediates PAN RNA stability, KSHV reactivation, and IFI16-related inflammasome activation.</name><description>N-acetyltransferase 10 (NAT10) is an N&lt;sup>4&lt;/sup>-acetylcytidine (ac&lt;sup>4&lt;/sup>C) writer that catalyzes RNA acetylation at cytidine N&lt;sup>4&lt;/sup> position on tRNAs, rRNAs and mRNAs. Recently, NAT10 and the associated ac&lt;sup>4&lt;/sup>C have been reported to increase the stability of HIV-1 transcripts. Here, we show that NAT10 catalyzes ac&lt;sup>4&lt;/sup>C addition to the polyadenylated nuclear RNA (PAN), a long non-coding RNA encoded by the oncogenic DNA virus Kaposi's sarcoma-associated herpesvirus (KSHV), triggering viral lytic reactivation from latency. Mutagenesis of ac&lt;sup>4&lt;/sup>C sites in PAN RNA in the context of KSHV infection abolishes PAN ac&lt;sup>4&lt;/sup>C modifications, downregulates the expression of viral lytic genes and reduces virion production. NAT10 knockdown or mutagenesis eras</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-05-29T00:39:46.336Z</modification><creation>2025-02-18T23:52:45.855Z</creation></dates><accession>S-EPMC10564894</accession><cross_references><pubmed>37816771</pubmed><doi>10.1038/s41467-023-42135-3</doi></cross_references></HashMap>